Moxetumomab pasudotox
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Moxetumomab pasudotox, covering 2015-09-16 to 2018-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia [Phase 3]